Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03171194 · ClinicalTrials.gov registry record · Phase 1
Pilot Trial of Mesenchymal Stem Cells for Systemic Lupus Erythematosus
A Phase 1 study, sponsored by Medical University of South Carolina.
- Completed
- Registry status
- Phase 1
- Development phase
- 6
- Enrollment target
NCT03171194 is a Phase 1 study that has completed, run by Medical University of South Carolina. The registered enrollment target is 6 participants.
The verdict
NCT03171194, a Phase 1 study, has completed, sponsored by Medical University of South Carolina.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 6 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the safety of mesenchymal stromal cells (MSCs) obtained from umbilical cords for the treatment of adults with active systemic lupus erythematosus (SLE).
Interventions
- DRUG Low Dose Mesenchymal Stem Cells (MSCs)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2017-04-27 |
| Est. Completion | 2018-10-25 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03171194
The ClinicalTrials.gov registry entry for NCT03171194 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medical University of South Carolina, which has 755 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Low Dose Mesenchymal Stem Cells (MSCs) is the first listed.
NCT03171194 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03171194 about?
NCT03171194 is a clinical study titled "Pilot Trial of Mesenchymal Stem Cells for Systemic Lupus Erythematosus". The purpose of this study is to evaluate the safety of mesenchymal stromal cells (MSCs) obtained from umbilical cords for the treatment of adults with active systemic lupus erythematosus (SLE).
What is the current status of trial NCT03171194?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 6 participants. The study started on 2017-04-27. Estimated completion is 2018-10-25.
What interventions are being tested in trial NCT03171194?
The interventions under investigation include: Low Dose Mesenchymal Stem Cells (MSCs) (DRUG).
Who is sponsoring clinical trial NCT03171194?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.